Mitsubishi UFJ Asset Management’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.83M Buy
284,510
+5,950
+2% +$104K ﹤0.01% 663
2025
Q4
$4.72M Buy
278,560
+9,813
+4% +$175K ﹤0.01% 670
2025
Q3
$4.85M Buy
268,747
+12,257
+5% +$207K ﹤0.01% 662
2025
Q2
$4.07M Buy
256,490
+9,837
+4% +$150K ﹤0.01% 679
2025
Q1
$4.17M Buy
246,653
+11,215
+5% +$186K ﹤0.01% 664
2024
Q4
$3.9M Hold
235,438
﹤0.01% 679
2024
Q3
$4.27M Sell
235,438
-11,208
-5% -$199K ﹤0.01% 675
2024
Q2
$4.06M Buy
246,646
+11,052
+5% +$169K 0.01% 663
2024
Q1
$3.33M Hold
235,594
﹤0.01% 690
2023
Q4
$3.98M Sell
235,594
-142,771
-38% -$2.18M 0.01% 645
2023
Q3
$5.78M Buy
378,365
+6,330
+2% +$112K 0.01% 569
2023
Q2
$7.02M Buy
372,035
+35,273
+10% +$681K 0.01% 542
2023
Q1
$6.51M Buy
336,762
+20,271
+6% +$408K 0.02% 533
2022
Q4
$6.23M Buy
316,491
+28,680
+10% +$563K 0.02% 532
2022
Q3
$6M Buy
287,811
+184,689
+179% +$4.69M 0.02% 510
2022
Q2
$2.88M Buy
103,122
+7,100
+7% +$211K 0.01% 640
2022
Q1
$3.01M Buy
96,022
+5,720
+6% +$180K 0.01% 657
2021
Q4
$3.06M Buy
90,302
+4,378
+5% +$146K 0.01% 678
2021
Q3
$2.55M Buy
85,924
+4,588
+6% +$134K 0.01% 699
2021
Q2
$2.17M Buy
81,336
+5,525
+7% +$156K 0.01% 724
2021
Q1
$2.09M Buy
75,811
+2,912
+4% +$81.4K 0.01% 686
2020
Q4
$2.01M Buy
72,899
+2,589
+4% +$68.3K 0.02% 654
2020
Q3
$1.83M Buy
70,310
+6,805
+11% +$179K 0.02% 603
2020
Q2
$1.68M Buy
63,505
+10,555
+20% +$270K 0.02% 578
2020
Q1
$1.29M Buy
52,950
+8,716
+20% +$263K 0.02% 567
2019
Q4
$1.32M Buy
44,234
+4,479
+11% +$134K 0.02% 643
2019
Q3
$1.17M Sell
39,755
-380
-0.9% -$10.6K 0.02% 595
2019
Q2
$1.1M Buy
40,135
+2,436
+6% +$68.6K 0.02% 611
2019
Q1
$1.08M Sell
37,699
-40
-0.1% -$1.11K 0.02% 564
2018
Q4
$948K Buy
37,739
+2,622
+7% +$69.5K 0.02% 542
2018
Q3
$937K Buy
35,117
+1,632
+5% +$45K 0.02% 607
2018
Q2
$903K Buy
33,485
+1,200
+4% +$30.5K 0.02% 608
2018
Q1
$854K Buy
32,285
+2,816
+10% +$75K 0.02% 610
2017
Q4
$879K Buy
29,469
+189
+0.6% +$5.72K 0.02% 621
2017
Q3
$873K Buy
29,280
+533
+2% +$16.2K 0.02% 594
2017
Q2
$894K Buy
28,747
+6,335
+28% +$200K 0.02% 602
2017
Q1
$705K Buy
22,412
+512
+2% +$15.5K 0.02% 649
2016
Q4
$633K Sell
21,900
-1,004
-4% -$29.5K 0.02% 663
2016
Q3
$747K Buy
22,904
+786
+4% +$26K 0.02% 627
2016
Q2
$715K Buy
22,118
+2,301
+12% +$69.3K 0.02% 622
2016
Q1
$583K Buy
19,817
+2,727
+16% +$75.6K 0.02% 643
2015
Q4
$461K Buy
17,090
+850
+5% +$21.9K 0.01% 663
2015
Q3
$398K Buy
16,240
+600
+4% +$14.8K 0.01% 677
2015
Q2
$375K Buy
15,640
+1,900
+14% +$48.6K 0.01% 718
2015
Q1
$383K Buy
13,740
+1,640
+14% +$46.1K 0.01% 693
2014
Q4
$331K Buy
12,100
+1,325
+12% +$33.5K 0.01% 687
2014
Q3
$250K Buy
10,775
+3,225
+43% +$78.3K 0.01% 700
2014
Q2
$182K Buy
7,550
+500
+7% +$11.9K ﹤0.01% 733
2014
Q1
$161K Buy
7,050
+450
+7% +$9.8K ﹤0.01% 719
2013
Q4
$133K Sell
6,600
-600
-8% -$12.7K ﹤0.01% 716
2013
Q3
$151K Buy
7,200
+5,000
+227% +$108K ﹤0.01% 706
2013
Q2
$49K Buy
+2,200
New +$52.9K ﹤0.01% 771

Other funds holding HR